Plus Therapeutics holders back 2020 stock plan update
Plus Therapeutics, Inc. held its 2026 Annual Meeting of Stockholders, where stockholders approved all four proposals presented.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Plus Therapeutics, Inc. held its 2026 Annual Meeting of Stockholders, where stockholders approved all four proposals presented. The meeting covered director elections, auditor ratification, executive pay and an updated stock incentive plan.
Six directors were elected to terms ending at the 2027 annual meeting, each receiving over 11.8 million votes in favor, with more than 50.8 million broker non-votes recorded. Stockholders ratified CBIZ CPAs, P.C. as independent auditor for 2026 with 60.9 million votes for and 2.3 million against. On an advisory basis, stockholders approved compensation for named executive officers with about 10.4 million votes for and 3.4 million against. They also approved the sixth amendment and restatement of the 2020 Stock Incentive Plan, which received about 8.0 million votes for and 5.6 million against.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding record date: 171,550,698 shares
Shares represented at meeting: 64,857,321 shares
Auditor ratification votes for: 60,860,051 votes
+5 more
8 metrics
Shares outstanding record date
171,550,698 shares
Common stock issued and outstanding as of March 18, 2026
Shares represented at meeting
64,857,321 shares
Shares present in person virtually or by proxy at 2026 Annual Meeting
Auditor ratification votes for
60,860,051 votes
Ratification of CBIZ CPAs, P.C. as 2026 auditor
Auditor ratification votes against
2,292,062 votes
Ratification of CBIZ CPAs, P.C. as 2026 auditor
Say-on-pay votes for
10,389,498 votes
Advisory approval of named executive officer compensation
Stock plan amendment votes for
7,976,002 votes
Approval of sixth amendment and restatement of 2020 Stock Incentive Plan
Broker non-votes on Proposal 3
50,807,018 votes
Advisory vote on executive compensation
Broker non-votes on Proposal 4
50,807,018 votes
2020 Stock Incentive Plan sixth amendment and restatement
Key Terms
reverse stock split, broker non-votes, independent registered public accounting firm, advisory (non-binding) basis, +2 more
6 terms
reverse stock split financial
"All share amounts disclosed herein are presented before giving effect to the Company’s 1-for-25 reverse stock split effective on April 2, 2026."
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
broker non-votes regulatory
"Votes For ... Votes Withheld ... Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm regulatory
"ratified the appointment of CBIZ CPAs, P.C. as the Company’s independent registered public accounting firm for the 2026 fiscal year."
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
advisory (non-binding) basis regulatory
"approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers."
Stock Incentive Plan financial
"approved the sixth amendment and restatement of the Company’s 2020 Stock Incentive Plan."
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
inspector of elections regulatory
"The vote results detailed below represent final results as certified by the inspector of elections."
An inspector of elections is an independent person or firm appointed to oversee and verify shareholder voting at corporate meetings, ensuring ballots and proxies are collected, validated and accurately counted. Like a neutral referee or scoreboard operator, they protect the integrity of votes that decide board members, mergers or other major actions, so investors can trust that outcomes reflect the true will of shareholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Plus Therapeutics (PSTV) stockholders approve at the 2026 Annual Meeting?
Stockholders approved all four proposals: election of six directors, ratification of CBIZ CPAs, P.C. as auditor, an advisory say-on-pay vote for named executive officers, and the sixth amendment and restatement of the 2020 Stock Incentive Plan.
How did Plus Therapeutics (PSTV) stockholders vote on director elections in 2026?
Six directors received between 11.86 million and 12.42 million votes for, with 1.63 million to 2.19 million votes withheld for each, and 50,807,018 broker non-votes. All nominees were elected to serve until the 2027 annual meeting and until their successors are duly elected and qualified.
What were the 2026 auditor ratification vote results for Plus Therapeutics (PSTV)?
Stockholders ratified CBIZ CPAs, P.C. as independent registered public accounting firm for 2026 with 60,860,051 votes for, 2,292,062 votes against, and 1,705,208 abstentions. There were no broker non-votes on this proposal, indicating broad participation on the auditor ratification item.
How did Plus Therapeutics (PSTV) stockholders vote on executive compensation in 2026?
On an advisory, non-binding basis, stockholders approved compensation of named executive officers with 10,389,498 votes for, 3,364,694 votes against, and 296,111 abstentions. There were 50,807,018 broker non-votes, which were not counted as votes for or against this say-on-pay proposal.
What were the results for Plus Therapeutics’ 2020 Stock Incentive Plan amendment in 2026?
The sixth amendment and restatement of the 2020 Stock Incentive Plan was approved with 7,976,002 votes for, 5,648,887 votes against, and 425,414 abstentions. In addition, 50,807,018 broker non-votes were recorded, which did not affect the approval outcome for this equity compensation plan change.
AI-generated analysis. How Rhea-AI works. Not financial advice.
